Bayer Investor News | Bayer Global

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 479 News

1 - 10of 479 News

July 02, 2026

Bayer Group to consolidate U.S. glyphosate business into distinct entity operating as Ruveon

June 25, 2026

Monsanto wins landmark Roundup™ case at U.S. Supreme Court

June 25, 2026

Immediate statement: US Supreme Court rules in favor of Monsanto in the Durnell case

June 17, 2026

Federal judge remands Monsanto class settlement case back to Missouri State Court

June 17, 2026

Not intended for UK Media

Bayer completes acquisition of Perfuse Therapeutics

June 15, 2026

Bayer’s low-dose MRI contrast agent approved in U.S.

June 10, 2026

European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke

June 09, 2026

Jana Marlen Ackermann to be new Head of Investor Relations at Bayer

May 19, 2026

Not intended for U.S. and UK Media

New drug applications for Bayer’s FXIa inhibitor accepted by U.S. Food and Drug Administration under Priority Review and by Japan’s Ministry of Health, Labour and Welfare

May 12, 2026

First quarter of 2026:

Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk